ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Markets

Hang Seng Index adds pharma and apparel companies

Hong Kong's blue chip benchmark drops Bank of East Asia and China Merchants Port

The Bank of East Asia and China Merchants Port Holdings will be dropped from the blue chip index.   © Reuters

HONG KONG -- Sino Biopharmaceutical and Shenzhou International Group will become part of the 50-member Hang Seng Index next month, the operator of the Hong Kong benchmark said Friday.

The Bank of East Asia and China Merchants Port Holdings will be dropped from the index, based on a quarterly review of blue chips. Those two companies are part of the Nikkei Asia300 Index.

The changes take effect Sept. 10, according to Hang Seng Indexes.

Shenzhou International, headquartered on the mainland, is a contract producer of knit apparel whose clients include Nike and Adidas. China Merchants Port is a port operator based in Hong Kong.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media